Adults with disabilities deserve right to choose where to live
The idea that one residential model is appropriate for the entire spectrum of intellectual and developmental disability is patently absurd.
The idea that one residential model is appropriate for the entire spectrum of intellectual and developmental disability is patently absurd.
President Donald Trump’s proposed cut for the U.S. National Institutes of Health’s 2018 budget could stall advances in science for generations.
Scott Gottlieb is poised to become chief of the U.S. Food and Drug Administration, neuroscience research has blossomed over the past decade, and new grants support adults with autism.
The Chan Zuckerberg Initiative has pledged to provide financial support for bioRxiv, a website where researchers can share manuscripts before peer review.
Children with chronic conditions are especially vulnerable to health insurance changes, as they often rely on specialists and medications that may not be covered if they switch plans.
Eight pharmaceutical companies more than doubled their lobbying spending in the first three months of 2017.
Tens of thousands of people protested the U.S. administration’s anti-science policies on Saturday.
Facing acute risks to their businesses from Washington policymakers, health companies spent more than $2 million to buy access to the incoming Trump administration via candlelight dinners, black-tie balls and other inauguration events.
The March for Science is finally here, the scientific workforce is aging at an alarming rate, and a pint-size podcaster tackles serious science.
Both the Pharmaceutical Research and Manufacturers of America and the nonprofit group have gone to great lengths to show that drugmakers are not driving what they describe as a “grass-roots” effort to fight imports.